Literature DB >> 2582059

Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA.

P H Van der Meide, M Dubbeld, H Schellekens.   

Abstract

Two stable hybridoma cell lines secreting specific antibodies against human gamma interferon (HuIFN-gamma) were established. Both monoclonal antibodies (designated as MD-1 and MD-2) belong to the IgG1/kappa subclass and neutralize the antiviral activity of natural and recombinant DNA derived HuIFN-gamma (nHuIFN-gamma and rHuIFN-gamma respectively), although MD-1 is far more effective than MD-2. MD-1 and MD-2 recognize different epitopes and do not compete with each other in binding to HuIFN-gamma as concluded from competition assays. In a 'Western' blot, both antibodies reacted with the 20 kDa and 25 kDa polypeptides present in nHuIFN-gamma preparations. A sandwich enzyme immunoassay using microtiter plates coated with unlabeled MD-2 was developed. Biotinylated MD-1 was used as the second antibody. Bound MD-1 was detected by an avidin/alkaline phosphatase enzyme reaction. This immunoassay is highly specific and as sensitive as a bioassay. A radioimmunoassay using MD-2 coated on polystyrene balls and 125I-labeled MD-1 as the second antibody showed a sensitivity comparable to that of the enzyme immunoassay.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582059     DOI: 10.1016/0022-1759(85)90109-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  30 in total

1.  Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.

Authors:  R T Meijer; S L Yong; I J ten Berge; R A van Lier; P T Schellekens
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.

Authors:  H M Diepolder; J T Gerlach; R Zachoval; R M Hoffmann; M C Jung; E A Wierenga; S Scholz; T Santantonio; M Houghton; S Southwood; A Sette; G R Pape
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Interleukin-12 suppresses immunoglobulin E production but enhances immunoglobulin G4 production by human peripheral blood mononuclear cells.

Authors:  B A de Boer; Y C Kruize; P J Rotmans; M Yazdanbakhsh
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells.

Authors:  S M Lens; P A Baars; B Hooibrink; M H van Oers; R A van Lier
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

5.  Plateau absorbance measurements: an alternative approach to enzyme activity determination illustrated by the example of alkaline phosphatase.

Authors:  P Van Duijn; C J Van Noorden
Journal:  Histochem J       Date:  1989 Sep-Oct

6.  Monocyte-mediated suppression of anti-DNA antibody production in healthy subjects.

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Kinoshita; R Yokohari
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

7.  Effect of anticancer drugs on the release of interferon gamma in vitro.

Authors:  K Ahmed; P H van der Meide; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

8.  Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis.

Authors:  A Stallmach; F Schäfer; S Hoffmann; S Weber; I Müller-Molaian; T Schneider; G Köhne; K W Ecker; G Feifel; M Zeitz
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

9.  The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes.

Authors:  M Kloppenburg; B M Brinkman; H H de Rooij-Dijk; A M Miltenburg; M R Daha; F C Breedveld; B A Dijkmans; C Verweij
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Effect of low-dose ultraviolet-B radiation on the function of human T lymphocytes in vitro.

Authors:  M B Teunissen; R M Sylva-Steenland; J D Bos
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.